reference/7120157

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7120157

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial
endingPage	129
issn	0924-8579
issueIdentifier	2
pageRange	119-129
publicationName	International Journal of Antimicrobial Agents
startingPage	119
bibliographicCitation	Petitpretz P, Chidiac C, Soriano F, Garau J, Stevenson K, Rouffiac E; 556 Clinical Study Group. The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults. Int J Antimicrob Agents. 2002 Aug;20(2):119–29. doi: 10.1016/s0924-8579(02)00126-7. PMID: 12297361.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f184a52847e8faa9c6bcb4d1c158316c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea8f8b38bdbadfdf62beb5117db513bd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_343e106009b42cee02e96675fe4eac1d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d87644373494f790b43e2d718a82be55 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e10a9075cece71a899263c5cc31dc9f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_566b74d1bfc76e798c506468b4d8af4e
date	200208
identifier	https://doi.org/10.1016/s0924-8579%2802%2900126-7 https://pubmed.ncbi.nlm.nih.gov/12297361
isPartOf	https://portal.issn.org/resource/ISSN/0924-8579 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20952
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	The efficacy and safety of oral pharmacokinetically enhanced amoxycillin–clavulanate 2000/125 mg, twice daily, versus oral amoxycillin–clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults
discusses	http://id.nlm.nih.gov/mesh/M0029678 http://id.nlm.nih.gov/mesh/M0448397
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D019980Q000009 http://id.nlm.nih.gov/mesh/D004359Q000009 http://id.nlm.nih.gov/mesh/D018410Q000188 http://id.nlm.nih.gov/mesh/D019980Q000627 http://id.nlm.nih.gov/mesh/D017714Q000188 http://id.nlm.nih.gov/mesh/D004359Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006193Q000187 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D010403 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D004359Q000008 http://id.nlm.nih.gov/mesh/D006193Q000302 http://id.nlm.nih.gov/mesh/D011018Q000382 http://id.nlm.nih.gov/mesh/D011018Q000188 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D018410Q000382 http://id.nlm.nih.gov/mesh/D013296Q000187 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D008826 http://id.nlm.nih.gov/mesh/D019980Q000008 http://id.nlm.nih.gov/mesh/D017714Q000382 http://id.nlm.nih.gov/mesh/D013296Q000302 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D004359Q000493 http://id.nlm.nih.gov/mesh/D000900Q000494 http://id.nlm.nih.gov/mesh/D019980Q000493
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8911 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33613 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665637 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280980

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136137642 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53790640 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135769296

Total number of triples: 61.